Leading contract manufacturer in North America serving top global innovator pharma companies.
Leading contract manufacturer in North America serving top global innovator pharma companies.
CDMO – Sterile Injectables
Jubilant HollisterStier, a subsidiary of Jubilant Pharmova Limited, provides comprehensive sterile fill-finish and lyophilization services, ensuring the consistent delivery of high-quality products that meet the needs of global healthcare markets and patients worldwide. With decades of experience, they offer a flexible and collaborative partnership model for manufacturing excellence that enables clients to increase speed to market with full regulatory confidence.
Jubilant HollisterStier
Jubilant HollisterStier LLC (JHS), is a subsidiary of Jubilant Pharmova Limited with operations in Spokane, Washington (USA) and Montréal (Canada).
- Sterile fill-finish injectables CDMO specializing in complex biologics and lyophilization with isolator capabilities
- Programs supported by highly tenured teams and cross-functional coordination
- Experienced project managers and account leaders proactively share information, respond quickly to any concerns, and collaborate on finding solutions
- Designed to support speed-to-market needs with regulatory confidence expectations
- Ongoing site initiatives include expansion projects focused on technology and capacity
Liquid Fill-Finish
JHS’s fill-finish programs are supported by decades of sterile
manufacturing experience, combining expertise and state-of-the-art technology to deliver
high quality products.
- Sterile liquid fill-finish service capability
- Project management approach tailored to program needs with clear governance
- Consistent status communication to support planning and decision-making
- Quality-driven execution aligned to controlled handling and batch consistency
- Supported by ongoing investments that expand capability and capacity over time
Lyophilization Services
Lyophilized sterile fill-finish services are delivered through integrated lyophilization systems and sterile filling operations designed to protect drug product integrity across processing steps within sterile manufacturing facilities.
- Advanced lyophilizers with full line integration and automation
- –60°C cold shelf loading capability
- CIP/SIP systems (clean-in-place / steam-in-place)
- Integration with filling lines to support product integrity at every stage
- Execution supported by defined operational practices for repeatable sterile processing
Inspection, Packaging and Support
JHS offers end-to-end inspection and packaging services to protect sterile
drug products as they ship to patients around the world. With a range of inspection
modalities and custom packaging options available, JHS matches each product with a
solution that fits its unique profile.
-90e91636-328a-4f73-8a82-97709b8f8c1f.jpg)
- End-to-end inspection and packaging services for sterile drug products
- Range of visual inspection modalities including manual, semi-automated, and automated visual inspection depending on product needs
- Tailored cartoning, labeling, and serialization options aligned to product and market requirements
- New inspection and packaging capabilities with an automated inspection machine (AIM) fully integrated with packaging line for 600 vial/minute top speed
Regulatory Support and Compliance
Supported by a robust Quality Management System (QMS), JHS quality and compliance
experts work with regulatory bodies worldwide to help partners navigate complex
regulatory landscapes with confidence.
- Dedicated regulatory affairs support for submissions and readiness planning
- Experience with FDA, EMA, PMDA (Japan), Health Canada, and others
- Consistent focus on everyday inspection readiness
- Supported dozens of approvals and NPIs, including sterile complex formulations
- Proactive approach to risk management and real-time support during execution
The JHS Advantage
The JHS Spokane facility features legal and technological infrastructure to support
operational continuity and ensure a reliable patient supply.
-2203925b-fd02-4e93-a3c5-cd193b820e8e.jpg)
- FTZ subzone covering entire Spokane site offers opportunities for partners to save time, reduce costs, increase flexibility and access other strategic advantages while remaining full compliant
- Robust supply chains strategy focused on streamlining efficiency, building resilience, and reducing lead times
- Thousands of square feet of validated cold storage warehouse space down to –80C
Manufacturing Sites
JHS operates sterile manufacturing sites in Spokane, Washington (USA) and Montréal, Quebec (Canada), supported by expansion programs focused on sterile fill-finish, lyophilization, and temperature-controlled storage.
Spokane, Washington (USA)
Sterile fill-finish and lyophilization for clinical and commercial supply. The site uses isolator technology and automated inspection and has a stated FDA inspection track record. Expansion progress includes Line 3 commissioned in February 2024. A fourth high-speed liquid filling line is planned for 2026, as part of a 160,000 sq. ft. site expansion that adds ultra-cold and temperature-controlled storage.
.png)
.png)
Montréal, Quebec (Canada)
The site is expanding under a stated $114M investment with a goal to increase annual injectables capacity from 20 million to 70 million (alongside existing ophthalmic capabilities). A 200 bottles-per-minute filling line, for three-piece and preservative-free bottles, is u